Literature DB >> 34694417

Rapid Enlargement of Vitiligo Vulgaris after Initiation of Dupilumab for Atopic Dermatitis: A Case Report.

Shintaro Takeoka, Masahiro Kamata1, Ikumi Yokoi, Aya Takehara, Yayoi Tada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34694417      PMCID： PMC9425561          DOI： 10.2340/actadv.v101.545

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  10 in total

1.  Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.

Authors:  Lili Yang; Yi Wei; Yue Sun; Weimin Shi; Ji Yang; Lubing Zhu; Ming Li
Journal:  Acta Derm Venereol       Date:  2015-07       Impact factor: 4.437

2.  Case of alopecia areata during dupilumab treatment for atopic dermatitis.

Authors:  Naoko Kanda; Mototaka Koto; Toshihiko Hoashi; Hidehisa Saeki
Journal:  J Dermatol       Date:  2019-04-03       Impact factor: 4.005

3.  Development of alopecia in patients treated with dupilumab.

Authors:  Nolan J Maloney; Scott Worswick; Kyle Cheng
Journal:  Dermatol Ther       Date:  2019-03-18       Impact factor: 2.851

4.  Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study.

Authors:  H Uchida; M Kamata; I Mizukawa; A Watanabe; A Agematsu; M Nagata; S Fukaya; K Hayashi; A Fukuyasu; T Tanaka; T Ishikawa; T Ohnishi; Y Tada
Journal:  Br J Dermatol       Date:  2019-08-22       Impact factor: 9.302

5.  One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study.

Authors:  Hideaki Uchida; Masahiro Kamata; Aika Kato; Itsumi Mizukawa; Ayu Watanabe; Ai Agematsu; Mayumi Nagata; Saki Fukaya; Kotaro Hayashi; Atsuko Fukuyasu; Takamitsu Tanaka; Takeko Ishikawa; Takamitsu Ohnishi; Yayoi Tada
Journal:  J Am Acad Dermatol       Date:  2020-05-29       Impact factor: 11.527

6.  Alopecia areata development in atopic dermatitis patients treated with dupilumab.

Authors:  S Ständer; Y Trense; D Thaçi; R J Ludwig
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-19       Impact factor: 6.166

7.  Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

Authors:  Eric L Simpson; Thomas Bieber; Emma Guttman-Yassky; Lisa A Beck; Andrew Blauvelt; Michael J Cork; Jonathan I Silverberg; Mette Deleuran; Yoko Kataoka; Jean-Philippe Lacour; Külli Kingo; Margitta Worm; Yves Poulin; Andreas Wollenberg; Yuhwen Soo; Neil M H Graham; Gianluca Pirozzi; Bolanle Akinlade; Heribert Staudinger; Vera Mastey; Laurent Eckert; Abhijit Gadkari; Neil Stahl; George D Yancopoulos; Marius Ardeleanu
Journal:  N Engl J Med       Date:  2016-09-30       Impact factor: 91.245

Review 8.  Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata.

Authors:  Taisuke Ito; Reiko Kageyama; Shinsuke Nakazawa; Tetsuya Honda
Journal:  Exp Dermatol       Date:  2020-07-03       Impact factor: 3.960

9.  CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin.

Authors:  Stanley Cheuk; Heinrich Schlums; Irène Gallais Sérézal; Elisa Martini; Samuel C Chiang; Nicole Marquardt; Anna Gibbs; Ebba Detlofsson; Andrea Introini; Marianne Forkel; Charlotte Höög; Annelie Tjernlund; Jakob Michaëlsson; Lasse Folkersen; Jenny Mjösberg; Lennart Blomqvist; Marcus Ehrström; Mona Ståhle; Yenan T Bryceson; Liv Eidsmo
Journal:  Immunity       Date:  2017-02-14       Impact factor: 31.745

10.  Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.

Authors:  Anna Wańkowicz-Kalińska; René M J G J van den Wijngaard; Bert J Tigges; Wiete Westerhof; Graham S Ogg; Vincenzo Cerundolo; Walter J Storkus; Pranab K Das
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.